These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 15251318

  • 21. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A, Arlen D, Barrett B, Boucher A, Cardella C, Cockfield SM, Rush D, Paraskevas S, Shapiro J, Shoker A, Yilmaz S, Zaltzman JS, Kiberd B.
    Transplantation; 2008 Oct 15; 86(7):953-60. PubMed ID: 18852662
    [Abstract] [Full Text] [Related]

  • 22. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials.
    Tian JH, Wang X, Yang KH, Liu AP, Luo XF, Zhang J.
    Transplant Proc; 2009 Nov 15; 41(9):3671-6. PubMed ID: 19917365
    [Abstract] [Full Text] [Related]

  • 23. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan 15; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 24. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
    Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C.
    Transplant Proc; 2005 Mar 15; 37(2):788-90. PubMed ID: 15848532
    [Abstract] [Full Text] [Related]

  • 25. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
    Medina-Pestana JO, Felipe CR, Park SI, Machado PG, Garcia R, Spinelli G, Silva LA, Santos CF, Tedesco-Silva H.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):74S-79S. PubMed ID: 15041311
    [Abstract] [Full Text] [Related]

  • 26. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L, Fonseca I, Almeida M, Henriques AC, Dias L, Sarmento AM, Cabrita A.
    Transplant Proc; 2005 Mar 15; 37(6):2755-8. PubMed ID: 16182802
    [Abstract] [Full Text] [Related]

  • 27. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May 15; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 28. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR.
    CMAJ; 1992 Sep 01; 147(5):645-57. PubMed ID: 1521210
    [Abstract] [Full Text] [Related]

  • 29. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
    Montagnino G, Banfi G, Campise MR, Passerini P, Aroldi A, Cesana BM, Ponticelli C.
    Nephrol Dial Transplant; 2004 Oct 01; 19(10):2622-9. PubMed ID: 15316096
    [Abstract] [Full Text] [Related]

  • 30. An analysis of predictors of long-term cadaveric renal allograft survival.
    Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, Fenton S, Robinette M, Zaltsman J, Bear R.
    Clin Transplant; 1995 Aug 01; 9(4):282-8. PubMed ID: 7579734
    [Abstract] [Full Text] [Related]

  • 31. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ.
    Transplantation; 1988 Feb 01; 45(2):406-9. PubMed ID: 3278434
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimus.
    Tedesco-Silva H, Garcia VD, Contieri FL, De Boni Monteiro de Carvalho D, Noronha IL, Gonçalves RT, de Paula FJ, Abbud-Filho M, Manfro RC, David-Neto E, Alfieri F, Ikehara E, Jiang Q, Tai SS, Medina-Pestana JO.
    Transplant Proc; 2010 Jun 01; 42(5):1659-66. PubMed ID: 20620495
    [Abstract] [Full Text] [Related]

  • 33. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.
    Transpl Immunol; 2008 Nov 01; 20(1-2):3-5. PubMed ID: 18773959
    [Abstract] [Full Text] [Related]

  • 34. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
    Wang D, Wu WZ, Yang SL, Chen JH, Tan JM.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1683-8. PubMed ID: 17097014
    [Abstract] [Full Text] [Related]

  • 35. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M, Iacob G, Lucan C, Lăpuşan C, Munteanu A, Sîrbu S.
    Transplant Proc; 2004 Mar 20; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [Abstract] [Full Text] [Related]

  • 36. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun 20; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 37. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Jun 20; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 38. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 39. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY, Chen JH, Wang YM, Zhang JG, Zhu C, Wang SY, Zhang P, Huang HF, He Q.
    Zhonghua Yi Xue Za Zhi; 2003 Jan 25; 83(2):106-9. PubMed ID: 12812676
    [Abstract] [Full Text] [Related]

  • 40. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P, Ortiz AM, Jara A, Vilches S.
    Transplant Proc; 2009 Jan 25; 41(1):127-30. PubMed ID: 19249495
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.